» Articles » PMID: 30804235

Exogenous Neural Stem Cell Transplantation for Cerebral Ischemia

Overview
Date 2019 Feb 27
PMID 30804235
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral ischemic injury is the main manifestation of stroke, and its incidence in stroke patients is 70-80%. Although ischemic stroke can be treated with tissue-type plasminogen activator, its time window of effectiveness is narrow. Therefore, the incidence of paralysis, hypoesthesia, aphasia, dysphagia, and cognitive impairment caused by cerebral ischemia is high. Nerve tissue regeneration can promote the recovery of the aforementioned dysfunction. Neural stem cells can participate in the reconstruction of the damaged nervous system and promote the recovery of nervous function during self-repair of damaged brain tissue. Neural stem cell transplantation for ischemic stroke has been a hot topic for more than 10 years. This review discusses the treatment of ischemic stroke with neural stem cells, as well as the mechanisms of their involvement in stroke treatment.

Citing Articles

Human iPSC-derived neural stem cells displaying radial glia signature exhibit long-term safety in mice.

Luciani M, Garsia C, Beretta S, Cifola I, Peano C, Merelli I Nat Commun. 2024; 15(1):9433.

PMID: 39487141 PMC: 11530573. DOI: 10.1038/s41467-024-53613-7.


Recent research of peptide-based hydrogel in nervous regeneration.

Xie C, Chen Y, Wang L, Liao K, Xue B, Han Y Bioact Mater. 2024; 40:503-523.

PMID: 39040568 PMC: 11261279. DOI: 10.1016/j.bioactmat.2024.06.013.


Na+/K+-ATPase: ion pump, signal transducer, or cytoprotective protein, and novel biological functions.

Huang S, Dong W, Lin X, Bian J Neural Regen Res. 2024; 19(12):2684-2697.

PMID: 38595287 PMC: 11168508. DOI: 10.4103/NRR.NRR-D-23-01175.


Recent advances in tissue repair of the blood-brain barrier after stroke.

Qi L, Wang F, Sun X, Li H, Zhang K, Li J J Tissue Eng. 2024; 15:20417314241226551.

PMID: 38304736 PMC: 10832427. DOI: 10.1177/20417314241226551.


Polymeric-Micelle-Based Delivery Systems for Nucleic Acids.

Sinani G, Durgun M, Cevher E, Ozsoy Y Pharmaceutics. 2023; 15(8).

PMID: 37631235 PMC: 10457940. DOI: 10.3390/pharmaceutics15082021.


References
1.
Doetsch F, Caille I, Lim D, Garcia-Verdugo J, Alvarez-Buylla A . Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999; 97(6):703-16. DOI: 10.1016/s0092-8674(00)80783-7. View

2.
Clarke D, Johansson C, Wilbertz J, Veress B, Nilsson E, Karlstrom H . Generalized potential of adult neural stem cells. Science. 2000; 288(5471):1660-3. DOI: 10.1126/science.288.5471.1660. View

3.
Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn K, Gebel J . Transplantation of cultured human neuronal cells for patients with stroke. Neurology. 2000; 55(4):565-9. DOI: 10.1212/wnl.55.4.565. View

4.
Carleton A, Petreanu L, Lansford R, Alvarez-Buylla A, Lledo P . Becoming a new neuron in the adult olfactory bulb. Nat Neurosci. 2003; 6(5):507-18. DOI: 10.1038/nn1048. View

5.
Barbash I, Chouraqui P, Baron J, Feinberg M, Etzion S, Tessone A . Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003; 108(7):863-8. DOI: 10.1161/01.CIR.0000084828.50310.6A. View